ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD68 Antibody [Y1/82A] (FITC) (A282011)

This product is discontinued

Anti-CD68 Antibody [Y1/82A] (FITC) (A282011) has been discontinued and is no longer available.

View all CD68 Antibodies.

Name
Anti-CD68 Antibody [Y1/82A] (FITC)
Description
Mouse monoclonal [Y1/82A] antibody to CD68 (FITC).
Specificity
This antibody recognises the human CD68 cell surface antigen, a ~110 kDa glycoprotein primarily expressed by macrophages and monocytes.
Applications
Flow Cytometry
Dilutions
FC 1: Neat, Use 10 µl of the suggested working dilution to label 1x106 cells in 100 µl
Reactivity
Human
Immunogen
Phytohaemagglutinin stimulated peripheral blood mononuclear cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
Y1/82A
Isotype
IgG2b
Conjugate

FITC

Excitation: 490nm, Emission: 525nm

Purification
Protein A affinity chromatography of tissue culture supernatant.
Concentration
100 µg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 1% BSA and 0.09% Sodium Azide.
Storage
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended. This product is photosensitive and should be protected from light.
General Notes
Mouse anti Human CD68 antibody, clone Y1/82A recognizes the human CD68 cell surface antigen, a ~110 kDa glycoprotein primarily expressed by macrophages and monocytes.
Synonyms
Gp110, Macrosialin
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-CD68 Antibody [Y1/82A] (FITC) (A282011)

Proteins predicted to interact with CD68

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
92.2% Relevancy Score
91.9% Relevancy Score
91.5% Relevancy Score
90.6% Relevancy Score
90.6% Relevancy Score
90% Relevancy Score
89.8% Relevancy Score
89.6% Relevancy Score
89.3% Relevancy Score